The company said recent facilities upgrades have expanded its capabilities to include commercial scale manufacturing of Schedule II controlled substances.
The Schedule II controlled substances are manufactured within a high security area of the company’s Rancho Cordova, California, facilities, reports sacbee.com.
AFC Product Management executive director Larry Zeagler said the company’s upgraded controlled substance facility can safely run hydrogenations and hazardous chemical processes.
"The recent upgrades satisfy DEA requirements for producing Schedule II intermediates and active pharmaceutical ingredients under current Good Manufacturing Practices (cGMP)," Zeagler added.
AFC is focused in process development, scale-up and cGMP-compliant commercial production of active pharmaceutical ingredients and registered intermediates for pharmaceutical and biotechnology customers.